When was MIV Therapeutics founded?

MIV Therapeutics was founded in 2003.

Where is MIV Therapeutics located?

MIV Therapeutics is headquartered in Surat, India.

How many employees does MIV Therapeutics have?

As of May 31, 2026, the latest employee count at MIV Therapeutics is 29.

Is MIV Therapeutics a funded company?

MIV Therapeutics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does MIV Therapeutics rank among its competitors?

MIV Therapeutics ranks 102nd amongst 126 active competitors, of which 35 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Thrombolex, which secured $50M in Feb, 2026.

Who are the top competitors of MIV Therapeutics?

MIV Therapeutics' top competitors include SMT, Aortyx and Thrombolex. Among them, Thrombolex secured the most recent funding round in February, 2026.

MIV Therapeutics - 2026 Company Profile & Competitors

Company Details

MIV Therapeutics develops devices focused on coronary and peripheral vascular procedures. Product offering includes Sirolimus eluting coronary stent system, CrCo coronary stent system, cobalt chromium coronary stent system, HAp coated coronary stent system, and Gen X CrCo coronary stent system. Purple Medical Solution acquired MIV Therapeutics in 2011.

Website: www.mivtindia.com/
Email ID: *****@mivtindia.com

Key Metrics

Founded Year

2003

Location

Surat, India

Stage

Acquired

Ranked

102^nd among 126 active competitors

Employee Count

29 as on May 31, 2026

Similar Companies

SMT & 161 more

Exit Details

Acquired by Purple Medical Solution (Jun 01, 2011)

View MIV Therapeutics' full profile

MIV Therapeutics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MIV THERAPEUTICS (INDIA) PRIVATE LIMITED CIN: U33112GJ2006PTC048811 , India, Amalgamated	Aug 01, 2006	₹10 - ₹50 Cr (As on Mar 31, 2019)	58 (As on Mar 31, 2020)
MIV THERAPEUTICS INC CIN: 10809204 , United States, Active	Dec 31, 2002	-	-	-

MIV Therapeutics got acquired by Purple Medical Solution on Jun 01, 2011.

Click here to take a look at MIV Therapeutics's acquisition in detail

MIV Therapeutics has not raised any funding rounds yet.

MIV Therapeutics' employee count trend

MIV Therapeutics has 29 employees as of May 26. Here is MIV Therapeutics's employee count trend over the years:

Employee count trend for MIV Therapeutics

Uncover MIV Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MIV Therapeutics include SMT, Aortyx and Thrombolex. Here is the list of Top 10 competitors of MIV Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SMT 1998, Surat (India), Late Stage	Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart	$93.5M	Samara Capital, Kotak Mahindra Bank & 105 others	71/100
2nd	Aortyx 2018, Barcelona (Spain), Series A	Developer of smart devices for aortic diseases	$15.8M	Clave, Ship2B Ventures & 8 others	54/100
3rd	Thrombolex 2016, Doylestown (United States), Series A	Developer of endovascular catheters for acute venous thromboembolic conditions	$67.8M	Orbimed, HHS	54/100
4th	Medyria 2012, Winterthur (Switzerland), Series B	Developer of technology for endovascular catheter navigation and sensing	$12.3M	Verve Ventures, Yellowstone Holding & 9 others	53/100
5th	Terumo Medical 1921, Shibuya (Japan), Funding Raised	Provider of a portfolio of medical devices for interventional cardiology	-	USAGov, BCM Technologies	52/100
6th	Vascular Solutions 1997, Minneapolis (United States), Acquired	Products for vascular diagnostics and interventional procedures	$12M	SpringRock Ventures, Stephens & 3 others	52/100
7th	iHeart 2013, Kyoto (Japan), Series D	Experts in regenerative medicine	$5.44M	Japan Asia Investment, Miyako Capital & 5 others	51/100
8th	Cardiovascular Systems 1989, Saint Paul (United States), Acquired	Developer of devices for treating peripheral and coronary vascular disease	$121M	Maverick Ventures, Mitsui Global Investment ... & 6 others	50/100
9th	Sonovascular 2017, Chapel Hill (United States), Series A	eveloper of a medical device to treat arterial and venous diseases	$6M	NC State University, Harbright Ventures & 1 others	50/100
10th	Spectranetics GSM 1984, Colorado Springs (United States), Acquired	Healthcare technology leader improving health through meaningful innovation	-	Novo Holdings, USVP & 1 others	50/100
102nd	MIV Therapeutics 2003, Surat (India), Acquired	Develops devices for coronary and peripheral vascular procedures	-	-	24/100